A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapyGautam Borthakur, Jörge E. Cortes|Haematologica|2015Cited by 58
A global study for acute myeloid leukemia with <i>RARG</i> rearrangementHong‐Hu Zhu, Suning Chen, Lijun Wen et al.|Blood Advances|2023Cited by 26